Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria

Background: Implementation of health programs to reduce cardiovascular risk, are needed for secondary prevention of cardiovascular diseases. Aim: To evalúate achievements of secondary prevention goals, pharmacologic prescription and major cardiovascular events in patients with coronary artery disease. Material and Methods: Patients who had a first event of acute coronary syndrome, angioplasty or revascularization surgery, between January 2008 and June 2010, were contacted for a clinical and laboratory evaluation between June and October 2011. Results: Seven hundred and two medical records were reviewed and 245 eligible patients were identified. Ofthese, we assessed 202 patients aged 64 ± 10 years (70% males). Sixty seven percent had two ormore cardiovascular riskfactors. A goal ofHDL cholesterol level over 40 mg/dL was achieved in 91 % of patients, smoking cessation in 84% and a total cholesterol < 200 mg/dL in 66%. A blood pressure below 130/85 mm Hgwas achieved in 30% of patients, a normal BMI in 19% and LDL cholesterol levels below 70 mg/dL in 18%. At the moment of assessment, 87%&gt; were using aspirin, 78%&gt; statins, 74% angiotensin converting enzyme inhibitors or angiotensin II receptor antagonists and 66%o were using &#946; - blockers. Twenty two percent of patients had a major cardiovascular event during the follow up, which lasted 28 ± 8 months. Conclusions: A low percentage of cardiovascular goals achievement was observed in this sample of patients, with a high prevalence of overweight and obesity. A high percentage quit smoking after their first cardiovascular event. Despite the high percentage of drug prescription, hypertension and dyslipidemia were not fully controlled.

Saved in:
Bibliographic Details
Main Authors: Neira V,Víctor, Potthoff N,Marcelo, Quiñiñir S,Luis, López R,Gabriel, Stockins F,Benjamín, Castillo B,Carlos, Lanas Z,Fernando
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2013
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000700006
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872013000700006
record_format ojs
spelling oai:scielo:S0034-988720130007000062013-12-17Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronariaNeira V,VíctorPotthoff N,MarceloQuiñiñir S,LuisLópez R,GabrielStockins F,BenjamínCastillo B,CarlosLanas Z,Fernando Coronary artery disease Secondary prevention Background: Implementation of health programs to reduce cardiovascular risk, are needed for secondary prevention of cardiovascular diseases. Aim: To evalúate achievements of secondary prevention goals, pharmacologic prescription and major cardiovascular events in patients with coronary artery disease. Material and Methods: Patients who had a first event of acute coronary syndrome, angioplasty or revascularization surgery, between January 2008 and June 2010, were contacted for a clinical and laboratory evaluation between June and October 2011. Results: Seven hundred and two medical records were reviewed and 245 eligible patients were identified. Ofthese, we assessed 202 patients aged 64 ± 10 years (70% males). Sixty seven percent had two ormore cardiovascular riskfactors. A goal ofHDL cholesterol level over 40 mg/dL was achieved in 91 % of patients, smoking cessation in 84% and a total cholesterol < 200 mg/dL in 66%. A blood pressure below 130/85 mm Hgwas achieved in 30% of patients, a normal BMI in 19% and LDL cholesterol levels below 70 mg/dL in 18%. At the moment of assessment, 87%&gt; were using aspirin, 78%&gt; statins, 74% angiotensin converting enzyme inhibitors or angiotensin II receptor antagonists and 66%o were using &#946; - blockers. Twenty two percent of patients had a major cardiovascular event during the follow up, which lasted 28 ± 8 months. Conclusions: A low percentage of cardiovascular goals achievement was observed in this sample of patients, with a high prevalence of overweight and obesity. A high percentage quit smoking after their first cardiovascular event. Despite the high percentage of drug prescription, hypertension and dyslipidemia were not fully controlled.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.141 n.7 20132013-07-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000700006es10.4067/S0034-98872013000700006
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language Spanish / Castilian
format Digital
author Neira V,Víctor
Potthoff N,Marcelo
Quiñiñir S,Luis
López R,Gabriel
Stockins F,Benjamín
Castillo B,Carlos
Lanas Z,Fernando
spellingShingle Neira V,Víctor
Potthoff N,Marcelo
Quiñiñir S,Luis
López R,Gabriel
Stockins F,Benjamín
Castillo B,Carlos
Lanas Z,Fernando
Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria
author_facet Neira V,Víctor
Potthoff N,Marcelo
Quiñiñir S,Luis
López R,Gabriel
Stockins F,Benjamín
Castillo B,Carlos
Lanas Z,Fernando
author_sort Neira V,Víctor
title Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria
title_short Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria
title_full Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria
title_fullStr Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria
title_full_unstemmed Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria
title_sort logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria
description Background: Implementation of health programs to reduce cardiovascular risk, are needed for secondary prevention of cardiovascular diseases. Aim: To evalúate achievements of secondary prevention goals, pharmacologic prescription and major cardiovascular events in patients with coronary artery disease. Material and Methods: Patients who had a first event of acute coronary syndrome, angioplasty or revascularization surgery, between January 2008 and June 2010, were contacted for a clinical and laboratory evaluation between June and October 2011. Results: Seven hundred and two medical records were reviewed and 245 eligible patients were identified. Ofthese, we assessed 202 patients aged 64 ± 10 years (70% males). Sixty seven percent had two ormore cardiovascular riskfactors. A goal ofHDL cholesterol level over 40 mg/dL was achieved in 91 % of patients, smoking cessation in 84% and a total cholesterol < 200 mg/dL in 66%. A blood pressure below 130/85 mm Hgwas achieved in 30% of patients, a normal BMI in 19% and LDL cholesterol levels below 70 mg/dL in 18%. At the moment of assessment, 87%&gt; were using aspirin, 78%&gt; statins, 74% angiotensin converting enzyme inhibitors or angiotensin II receptor antagonists and 66%o were using &#946; - blockers. Twenty two percent of patients had a major cardiovascular event during the follow up, which lasted 28 ± 8 months. Conclusions: A low percentage of cardiovascular goals achievement was observed in this sample of patients, with a high prevalence of overweight and obesity. A high percentage quit smoking after their first cardiovascular event. Despite the high percentage of drug prescription, hypertension and dyslipidemia were not fully controlled.
publisher Sociedad Médica de Santiago
publishDate 2013
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000700006
work_keys_str_mv AT neiravvictor logrodemetasdeprevencionsecundariaprescripcionfarmacologicayeventoscardiovascularesmayoresenpacientesconenfermedadcoronaria
AT potthoffnmarcelo logrodemetasdeprevencionsecundariaprescripcionfarmacologicayeventoscardiovascularesmayoresenpacientesconenfermedadcoronaria
AT quininirsluis logrodemetasdeprevencionsecundariaprescripcionfarmacologicayeventoscardiovascularesmayoresenpacientesconenfermedadcoronaria
AT lopezrgabriel logrodemetasdeprevencionsecundariaprescripcionfarmacologicayeventoscardiovascularesmayoresenpacientesconenfermedadcoronaria
AT stockinsfbenjamin logrodemetasdeprevencionsecundariaprescripcionfarmacologicayeventoscardiovascularesmayoresenpacientesconenfermedadcoronaria
AT castillobcarlos logrodemetasdeprevencionsecundariaprescripcionfarmacologicayeventoscardiovascularesmayoresenpacientesconenfermedadcoronaria
AT lanaszfernando logrodemetasdeprevencionsecundariaprescripcionfarmacologicayeventoscardiovascularesmayoresenpacientesconenfermedadcoronaria
_version_ 1755988427819450368